Cofertility is a women‑founded fertility technology company that operates an egg‑sharing platform which lets eligible people freeze their eggs at no cost in exchange for donating a portion of retrieved eggs to intended parents, while also coordinating egg donation and related services for families seeking donor eggs[2][3]. Cofertility positions itself as a human‑first, tech‑enabled ecosystem combining clinical partnerships, member advocacy, and a marketplace‑style matching model to increase access, donor diversity, and affordability in third‑party reproduction[6][2].
High‑level overview
- Mission: Cofertility’s stated mission is to make egg freezing more accessible, egg donation less transactional, and fertility care more equitable, transparent, and human‑centered[3][6].
- Investment philosophy: (Not applicable — Cofertility is a portfolio/company, not an investment firm.)
- Key sectors: Fertility technology (femtech), reproductive health services, donor egg coordination and family‑building services[6][1].
- Impact on the startup ecosystem: Cofertility is part of a growing wave of femtech startups addressing reproductive care gaps by combining platform software, clinical partnerships, and community support; its Split egg‑sharing model has drawn investor interest and expanded public discussion about alternative, lower‑cost routes to egg preservation and donor eggs[2][3].
For a portfolio‑company style summary (what Cofertility builds, who it serves, problem solved, growth)
- Product: A coordinated egg‑sharing and egg‑donation platform (branded programs such as “Split” and other service tiers) plus member advocacy and clinic coordination tools[6][3].
- Customers: People seeking egg freezing and donors (members who want to preserve fertility) and intended parents seeking donor eggs[6][2].
- Problem solved: High cost and limited supply/diversity in donor egg markets and affordability barriers to egg freezing; Cofertility’s model reduces out‑of‑pocket cost for some freeze candidates and expands the pool of available donor eggs for families[2][3].
- Growth momentum: Cofertility raised a Series A reported at $7.25M in April 2025 (bringing total funding to about $16M) and reports hundreds of clinic partners and growing demand for its Split program[2][3][6].
Origin story
- Founders and background: Cofertility was co‑founded by Lauren Makler (previously at Uber; founder of Uber Health) and Halle Tecco, with Makler serving as CEO[2][5][3].
- How the idea emerged: The concept grew from Makler’s exploration of egg donation and a desire to build the service she would have wanted, focusing on reducing transactional aspects of donation and expanding access to egg freezing[5][3].
- Founding year and early evolution: Cofertility launched around 2022 and evolved into a tech‑enabled egg‑sharing platform that blends clinical partnerships with member support; the company raised a Series A in 2025 to scale its technology, operations, and clinic relationships[5][2][3].
- Early traction/pivotal moments: Public recognition and awards (e.g., being named a top egg‑freezing service by outlets citing its Split program), rapid clinic partner expansion, and the 2025 Series A were key inflection points that validated demand and investor confidence[4][2][3].
Core differentiators
- Unique program model: The Split egg‑sharing program that enables eligible members to freeze eggs for free by donating half the retrieved eggs to intended parents reduces cost barriers and increases donor supply[2][3].
- Human‑first service design: Dedicated Member Advocates who guide members through medical, logistical, and emotional steps distinguish Cofertility’s white‑glove approach from purely transactional marketplaces[6].
- Clinic partnerships and clinical standards: Cofertility emphasizes partnerships with top fertility clinics and board‑certified clinicians to maintain medical quality while coordinating logistics at scale[4][6].
- Focus on donor diversity and ethics: The company promotes donor diversity and reframes donation as empathetic collaboration rather than a purely commercial exchange[3][6].
- Technology and platform: Cofertility invests in a proprietary platform to manage matching, case coordination, and member journeys—positioning itself as more than a referral service[3][1].
Role in the broader tech landscape
- Trend alignment: Cofertility sits at the intersection of femtech, telehealth/coordination platforms, and marketplace models addressing healthcare‑access gaps[6][2].
- Why timing matters: Rising demand for fertility preservation, growing public awareness of reproductive options, and pressure to lower healthcare costs create an opening for nontraditional models that expand supply and affordability for donor eggs and egg freezing[2][3].
- Market forces in their favor: Investor interest in femtech, increased employer fertility benefits (which raise awareness), and a shortage of accessible, diverse donor pools support Cofertility’s expansion[2][3].
- Influence on ecosystem: By scaling an egg‑sharing model and normalizing donation as collaborative, Cofertility may encourage clinics and payers to rethink pricing, donor recruitment, and patient support standards across reproductive care[3][6].
Quick take & future outlook
- What’s next: Cofertility is focused on scaling its proprietary platform, expanding clinic partnerships, growing its team, and broadening awareness and advocacy to reduce stigma and increase access to egg freezing and donation[3].
- Trends that will shape them: Regulatory developments in reproductive health, employer benefits trends, advances in cryopreservation and genetics, and public attitudes toward egg donation and donor‑conceived families will all influence growth[2][4].
- How influence might evolve: If Cofertility sustains clinical quality while increasing supply and diversity of donor eggs, it could become a standard channel for donor‑intended parent matching and a model for ethically reframed fertility services; conversely, scaling will require careful clinical oversight, transparent outcomes, and regulatory navigation to maintain trust[3][4][2].
Quick take: Cofertility combines a distinctive egg‑sharing product, a human‑centered service model, and venture backing to attack cost and supply constraints in donor egg markets; its future impact will depend on execution at scale, clinical outcomes transparency, and how the market and regulators respond to its novel model[2][3][6].
If you’d like, I can:
- Summarize Cofertility’s reported funding, investor list, and key metrics in a compact table[3].
- Walk through the Split program step‑by‑step (eligibility, medical process, costs covered).
